Markers of increased cardiovascular risk: are we measuring the most appropriate parameters?
1Department of Medicine, Division of Endocrinology, Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Hawkins@aecom.yu.edu
Insights
Evaluating cardiovascular disease risk involves numerous factors. Specific lipid parameters like lipoprotein buoyancy and inflammatory markers offer improved prediction beyond traditional measures.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease (CVD) risk assessment is complex due to numerous contributing factors.
- Traditional risk factors like blood lipids are being refined for better accuracy.
- Systemic inflammation's role in atherosclerosis pathogenesis is increasingly acknowledged.
Purpose of the Study:
- To evaluate the predictive value of specific cardiovascular risk factors.
- To compare the efficacy of novel markers against traditional ones.
Main Methods:
- Analysis of traditional cardiovascular risk factors, including blood lipid levels.
- Assessment of advanced parameters such as lipoprotein buoyancy.
- Inclusion of inflammatory markers to gauge their association with disease risk.
Main Results:
- Specific lipoprotein parameters demonstrate superior predictive capability compared to total levels.
- Inflammatory markers are identified as significant contributors to cardiovascular risk.
- Studies aim to elucidate the individual predictive merits of these diverse factors.
Conclusions:
- Refined lipid analysis and inflammatory markers enhance cardiovascular risk prediction.
- A comprehensive approach integrating multiple factors is crucial for accurate patient assessment.
Abstract:
The vital task of evaluating cardiovascular disease risk in individual patients is challenging in light of the ever-growing list of risk factors. Some of the traditional measures of cardiovascular risk, such as blood lipid levels, have been further refined to provide better risk assessments. Certain specific parameters, such as lipoprotein buoyancy, seem to be better predictors of cardiovascular disease than total lipoprotein levels. Furthermore, as the contribution of systemic inflammation to the pathogenesis of atherosclerosis is increasingly recognized, several inflammatory markers have become associated with disease risk. Consequently, many studies have attempted to determine the individual merits of these factors in predicting cardiovascular risk.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Coronary Artery Disease I: Introduction
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:26Coronary Artery Disease IV: Preventive Measures
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT